Newbridge Financial Services Group’s ESSA Pharma EPIX Stock Holding History

Newbridge Financial Services Group’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31	Closed	-$96	–	1215
2023 Q3	$96	Hold	31	–	–	﹤0.01%	1249
2023 Q2	$84	Hold	31	–	–	﹤0.01%	1306
2023 Q1	$92	Hold	31	–	–	﹤0.01%	1364
2022 Q4	$78	Hold	31	–	–	﹤0.01%	1402
2022 Q3	$0	Hold	31	–	–	﹤0.01%	1410
2022 Q2	$0	Hold	31	–	–	﹤0.01%	1399
2022 Q1	$0	Hold	31	–	–	﹤0.01%	1469
2021 Q4	$0	Hold	31	–	–	﹤0.01%	1448
2021 Q3	$1K	Hold	31	–	–	﹤0.01%	1248
2021 Q2	$1K	Hold	31	–	–	﹤0.01%	1347
2021 Q1	$1K	Buy	+31	New	+$721	﹤0.01%	1261

Other funds holding EPIX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return